Copyright © DrugPatentWatch. Initially printed at New patent for International Blood drug OXBRYTA
Annual Drug Patent Expirations for OXBRYTA
Oxbryta is a drug marketed by International Blood Theraps and is included in two NDAs. There are 9 patents defending this drug.
This drug has 200 and thirty patent relations in thirty-seven nations.
The generic ingredient in OXBRYTA is voxelotor. Extra particulars can be found on the voxelotor profile web page.
For extra info on how DrugPatentWatch may help along with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially printed at New patent for International Blood drug OXBRYTA
